Originally Published MDDI December 2002
NEWS & ANALYSIS
Applied Medical's GelPort, a laparoscopic hand-access device, was selected as one of the innovations of the year by the Society of Laparoendoscopic Surgeons (SLS). "This award recognizes the most innovative products of the past year that have a multidisciplinary application in minimally invasive surgery," said SLS chairman Paul A. Wetter in a recent press release.
In the past, live kidney donors had to undergo an open surgery, which entails a 10–12-in. incision made across the patient's abdomen, the possible removal of a rib, and a long recovery period, according to Applied Medical's Web site. With GelPort, donors can expect a three-day hospital stay, a two- to three-week recovery, and significant reduction of pain and scarring.
The GelPort reportedly provides unlimited hand exchanges for surgeon confidence and control and good wound protection and retraction.
The device may help dissipate, or at least alleviate, many of the fears associated with kidney surgery—good news for the more than 50,000 patients awaiting a kidney in the United States.
Copyright ©2002 Medical Device & Diagnostic Industry